ArticleFoods (Basel, Switzerland)2025
Cost-Benefit Analysis of Enzymatic Hydrolysis Alternatives for Food Waste Management.
Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Aquafaba Hydrolysates as Functional Ingredients in Muffin Cakes: Effects on Physicochemical Properties, Quality Attributes, and Antioxidant Activity.Foods (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we aimed to evaluate the economic, environmental, and social viability of the enzymatic hydrolysis process for food waste valorization by applying cost-benefit analysi (CBA). Our research was based on the investigation of three scenarios/alternatives for the final product of the enzymatic hydrolysis process and the production of bioethanol, bioactive peptides, and organic acids. Key economic indicators, such as cost/benefit ratios, net present value (NPV), and internal rate of return (IRR), were used to evaluate financial performance. At the end of the CBA, a sensitivity analysis was conducted to highlight the performance of each scenario under varying conditions, including fluctuating costs, benefits, and discount rates. These results indicate that enzymatic hydrolysis offers a significant opportunity for reducing food waste and its environmental impacts and promotes sustainability. Bioactive peptide production was found to be the most environmentally viable option, offering the highest cost-benefit efficiency. In both the optimistic and pessimistic scenarios of the sensitivity analysis, the results revealed that bioactive peptide production is economically viable, while the other alternatives, such as bioethanol and organic acid production, are more sensitive to economic and operational changes. This study revealed that enzymatic hydrolysis, as evaluated through CBA, offers a viable and impactful method for food waste management. It reduces environmental impacts, enhances sustainability, and aligns with the principles of a circular economy. The adoption of such innovative waste management strategies is considered essential for building a more sustainable and resource-efficient food system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.